SOHO 2022: Characteristics of Patients With Myelofibrosis Taking Rux…

SOHO 2022 Tenth Annual Meeting

L. Masarova

SOHO 2022: Role of ddPCR in CML Today

SOHO 2022 Tenth Annual Meeting

J. Radich, S. Soverini

SOHO 2022: State of the Art in CML

SOHO 2022 Tenth Annual Meeting

M. Deininger, G. Saglio

SOHO 2022: Long-Term Outcomes After Haplo-SCT for Hematologic Malign…

SOHO 2022 Tenth Annual Meeting

S. Saengboon

GLOW Study - First Prospective Data on MRD Outcomes After Fixed-Dura…

SOHO 2022 Tenth Annual Meeting

C. Owen

SOHO 2022 Next Questions: CML

SOHO 2022 Tenth Annual Meeting

T. Hughes

SOHO 2022 Next Questions: CLL

SOHO 2022 Tenth Annual Meeting

F. Cymbalista

SOHO 2022 Next Questions: AML

SOHO 2022 Tenth Annual Meeting

H. Kantarjian

Next Questions: ALL

Lori Muffly

SOHO 2022: Orca-T Results in High GVHD-Free and Relapse-Free Surviva…

SOHO 2022 Tenth Annual Meeting

S. Srour

Supportive Therapy in CLL

SOHO 2022 Tenth Annual Meeting

C. Sun

CLL - Real World Data With Small Molecules

SOHO 2022 Tenth Annual Meeting

F. Cymbalista

CLL DEBATE: How Many Drugs Are Needed in 1L CLL?

SOHO 2022 Tenth Annual Meeting

A. Mato

CLL DEBATE: Combination Small Molecules vs. Sequencing in CLL - Pro …

SOHO 2022 Tenth Annual Meeting

J. Brown

SOHO 2022: Covalent BTK Inhibitors - How Do They Compare in CLL?

SOHO 2022 Tenth Annual Meeting

J. Byrd

Clinical Significance of B-Cell Receptor Stereotypy in CLL

SOHO 2022 Tenth Annual Meeting

K. Stamatopoulos

SOHO 2022: PACE and OPTIC Trials - Dose Modification Dynamics of Pon…

SOHO 2022 Tenth Annual Meeting

H. Kantarjian

SOHO 2022: Asciminib or Ponatinib for Multiresistant CML Patients?

SOHO 2022 Tenth Annual Meeting

J. Cortés

SOHO 2022: Immunotherapy - The Way Forward to Maximize TFR in CML?

SOHO 2022 Tenth Annual Meeting

D. Rea

SOHO 2022: Beyond TKI Therapy in CML

SOHO 2022 Tenth Annual Meeting

M. Copland

SOHO 2022: AGILE - A Phase 3, Global, Randomized, Double-Blind Study…

SOHO 2022 Tenth Annual Meeting

A. de la Fuente, C. DiNardo

SOHO 2022: Emerging CAR T-Cell Therapy Approaches in AML

SOHO 2022 Tenth Annual Meeting

S. Kenderian

SOHO 2022 AML DEBATE: Is MRD More Prognostic Than Initial Presentati…

SOHO 2022 Tenth Annual Meeting

C. Lindsley

SOHO 2022 AML DEBATE: Is MRD More Prognostic Than Initial Presentati…

SOHO 2022 Tenth Annual Meeting

M. Heuser

Is the Future of AML Therapy All Oral?

Farhad Ravandi

SOHO 2022: Non-Intensive Treatment of Elderly/Unfit Patients With AML

SOHO 2022 Tenth Annual Meeting

T. Kadia

SOHO 2022: How Do We Overcome Resistance to Venetoclax in AML

SOHO 2022 Tenth Annual Meeting

M. Konopleva

SOHO 2022: FLT3-Mutated AML - Triplet vs. Doublet Therapy

SOHO 2022 Tenth Annual Meeting

E. Wang

SOHO 2022: Menin Inhibitors in AML

SOHO 2022 Tenth Annual Meeting

E. Stein

SOHO 2022: Novel Chemotherapy Can Eliminate the Need for Transplant …

SOHO 2022 Tenth Annual Meeting

N. Short

SOHO 2022: Certain Patients With ALL Still Need a Transplant

SOHO 2022 Tenth Annual Meeting

J. Ribera, P. Scheinberg

SOHO 2022: Approach to ALL in the Elderly

SOHO 2022 Tenth Annual Meeting

M. Luskin

SOHO 2022: Management of Ph+ ALL in 2022

SOHO 2022 Tenth Annual Meeting

E. Jabbour

SOHO 2022: Phase II Study of Blinatumomab in Combination With Ponati…

SOHO 2022 Tenth Annual Meeting

F. Haddad

SOHO 2022: Dual Targeted CAR T-Cells for ALL

SOHO 2022 Tenth Annual Meeting

N. Frey

SOHO 2022: Approach to Ph-Like ALL

SOHO 2022 Tenth Annual Meeting

E. Curran

SOHO 2022: Blinatumomab in Pediatric ALL

SOHO 2022 Tenth Annual Meeting

S. Cooper

New BTKi in CLL

Catherine Coombs

Novel Agents in CLL

SOHO 2022 Tenth Annual Meeting

A. Danilov

SOHO 2022: BCL2i in CLL

SOHO 2022 Tenth Annual Meeting

A. Chanan-Khan

SOHO 2022: Childhood CML

SOHO 2022 Tenth Annual Meeting

F. Millot

SOHO 2022: Assessment and Management of TKI-Related AOEs in CML

SOHO 2022 Tenth Annual Meeting

G. Saglio

SOHO 2022: Non BCR-ABL Mutations in CML - Do They Matter?

SOHO 2022 Tenth Annual Meeting

S. Soverini

SOHO 2022: Advances in ALL Diagnosis and Treatment - The NOPHO Exper…

SOHO 2022 Tenth Annual Meeting

K. Schmiegelow

Approaches to and Use of MRD in ALL

Selina Luger

SOHO 2022: Allogeneic CAR T-Cells in ALL

SOHO 2022 Tenth Annual Meeting

N. Jain

SOHO 2022: Is TP53-Mutated AML the Same Disease as TP53-Mutated MDS?

SOHO 2022 Tenth Annual Meeting

P. Valk

SOHO 2022 Update on CD47 Targeting Antibodies

SOHO 2022 Tenth Annual Meeting

N. Daver

SOHO 2022: What Is the Best Strategy for Therapy-Related AML?

SOHO 2022 Tenth Annual Meeting

P. Desai